PHASE 2, OPEN LABEL EXTENSION STUDY TO INVESTIGATE THE LONG TERM SAFETY AND TOLERABILITY OF PF-06649751 IN SUBJECTS WITH

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2017
This article has no abstract
Epistemonikos ID: 718120b58707d5dcd8b372cf7f01a9b8d6a79444
First added on: Jul 27, 2021